In addition, while ERα expression is typically dichotomised as a binary variable, updated guidelines from the American Society of Clinical Oncology and College of American Pathologists (ASCO-CAP) propose that breast tumours with low levels of ERα expression (1–10%) be reported as ER-low-positive43. The gene discussed is ESR1; the disease is breast neoplasm.